Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06BQU
|
|||
| Former ID |
DNAP001622
|
|||
| Drug Name |
Salicin
|
|||
| Synonyms |
salicin; 138-52-3; Salicoside; Salicine; Salicyl alcohol glucoside; D-(-)-Salicin; (2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(2-(hydroxymethyl)phenoxy)tetrahydro-2H-pyran-3,4,5-triol; 2-(Hydroxymethyl)phenyl beta-D-glucopyranoside; Saligenin beta-D-glucopyranoside; D-Salicin; Saligenin-beta-D-glucopyranoside; 2-(Hydroxymethyl)phenyl-beta-d-glucopyranoside; Salicin (6CI,8CI); D(-)-Salicin; o-(Hydroxymethyl)phenyl beta-D-glucopyranoside; Benzyl alcohol, o-hydroxy-, o-glucoside; UNII-4649620TBZ; AI3-19099; alpha-Hydroxy-o-tolyl beta
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Analgesia [ICD-11: MB40.8; ICD-10: R20.0; ICD-9: 338] | Approved | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H18O7
|
|||
| Canonical SMILES |
C1=CC=C(C(=C1)CO)OC2C(C(C(C(O2)CO)O)O)O
|
|||
| InChI |
1S/C13H18O7/c14-5-7-3-1-2-4-8(7)19-13-12(18)11(17)10(16)9(6-15)20-13/h1-4,9-18H,5-6H2/t9-,10-,11+,12-,13-/m1/s1
|
|||
| InChIKey |
NGFMICBWJRZIBI-UJPOAAIJSA-N
|
|||
| CAS Number |
CAS 138-52-3
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
2286, 4628, 3134379, 8143994, 8149868, 10298351, 11335205, 11360444, 11364124, 11366686, 11369248, 11372115, 11374495, 11377410, 11461416, 11484508, 11488572, 11490763, 11492872, 11495044, 11537719, 12153396, 14824655, 24899442, 26612361, 26680016, 26754404, 36883715, 47216608, 47290962, 47365008, 47365009, 49972587, 50086599, 50109834, 56314645, 57403054, 78051830, 81092933, 85165117, 85843100, 87575634, 88196968, 92124552, 92298558, 92307624, 92711990, 99301118, 103579849, 104253606
|
|||
| ChEBI ID |
CHEBI:17814
|
|||
| Interaction between the Drug and Microbe | Top | |||
|---|---|---|---|---|
| The Metabolism of Drug Affected by Studied Microbe(s) | ||||
| The Order in the Taxonomic Hierarchy of the following Microbe(s): Lactobacillales | ||||
|
Studied Microbe: Lactobacillus acidophilus
Show/Hide Hierarchy
|
[2] | |||
| Hierarchy | ||||
| Metabolic Effect | Increase activity | |||
| Description | Salicin can be metabolized by Lactobacillus acidophilus, which results in the increase of the drug's activity. | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions. Expert Opin Drug Metab Toxicol. 2018 Oct;14(10):1043-1055. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.